Czech National Bank Buys 7,954 Shares of Danaher Corporation $DHR

Czech National Bank lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 4.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 179,298 shares of the conglomerate’s stock after acquiring an additional 7,954 shares during the quarter. Czech National Bank’s holdings in Danaher were worth $34,153,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in DHR. Norges Bank bought a new stake in Danaher during the 4th quarter valued at approximately $2,177,106,000. Viking Global Investors LP lifted its holdings in shares of Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after buying an additional 2,455,994 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Danaher by 104.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after acquiring an additional 2,216,789 shares during the period. Wellington Management Group LLP grew its stake in shares of Danaher by 11.2% in the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after acquiring an additional 1,517,904 shares during the last quarter. Finally, Capital International Investors increased its position in Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after acquiring an additional 1,487,768 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Trading Up 0.2%

Shares of DHR stock opened at $200.01 on Friday. The firm has a fifty day moving average of $190.23 and a 200-day moving average of $194.24. The stock has a market cap of $140.61 billion, a price-to-earnings ratio of 35.53, a P/E/G ratio of 2.49 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.77 earnings per share. On average, equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

DHR has been the subject of several research analyst reports. Evercore reiterated an “outperform” rating and set a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Robert W. Baird cut their price objective on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research report on Friday, April 17th. Royal Bank Of Canada increased their target price on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. JPMorgan Chase & Co. decreased their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, Citigroup assumed coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.